3-nitropropionic acid has been researched along with Tauopathies in 1 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
Excerpt | Relevance | Reference |
---|---|---|
"Tauopathies are a group of disorders in which the cytosolic protein tau aggregates and accumulates in cells within the brain, resulting in neurodegeneration." | 1.46 | Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy. ( Boxer, AL; Braunstein, J; Cairns, NJ; Finn, MB; Fogelman, I; Gallardo, G; Holtzman, DM; Hu, Y; Jiang, H; Kerwin, DR; Keyser, J; Knapik, SS; Miller, BL; Patel, TK; Robinson, G; Roh, J; Schindler, S; Stewart, F; Ulrich, JD; Verghese, PB; West, T; Yanamandra, K, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yanamandra, K | 1 |
Patel, TK | 1 |
Jiang, H | 1 |
Schindler, S | 1 |
Ulrich, JD | 1 |
Boxer, AL | 1 |
Miller, BL | 1 |
Kerwin, DR | 1 |
Gallardo, G | 1 |
Stewart, F | 1 |
Finn, MB | 1 |
Cairns, NJ | 1 |
Verghese, PB | 1 |
Fogelman, I | 1 |
West, T | 1 |
Braunstein, J | 1 |
Robinson, G | 1 |
Keyser, J | 1 |
Roh, J | 1 |
Knapik, SS | 1 |
Hu, Y | 1 |
Holtzman, DM | 1 |
1 other study available for 3-nitropropionic acid and Tauopathies
Article | Year |
---|---|
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.
Topics: Animals; Antibodies; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; | 2017 |